Kesler Norman & Wride’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-538	Closed	-$217K	–	230
2024 Q4	$217K	Sell	538 -965	-64%	-$389K	0.05%	209
2024 Q3	$699K	Buy	+1,503	New	+$699K	0.14%	136